BAD and SFN |
BCL2 associated agonist of cell death |
stratifin |
- Activation of BAD and translocation to mitochondria
- Activation of BAD and translocation to mitochondria
- BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
- NRAGE signals death through JNK
- AKT phosphorylates targets in the cytosol
- Constitutive Signaling by AKT1 E17K in Cancer
|
- Activation of BAD and translocation to mitochondria
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- RHO GTPases activate PKNs
- TP53 Regulates Metabolic Genes
- TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
- Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
- Regulation of localization of FOXO transcription factors
|
|
|
|
|
BAG1 and MAPT |
BAG cochaperone 1 |
microtubule associated protein tau |
- Regulation of HSF1-mediated heat shock response
|
- Caspase-mediated cleavage of cytoskeletal proteins
|
- (2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
|
- Lansoprazole
- Astemizole
- Paclitaxel
- Docetaxel
|
|
- Amyotrophic lateral sclerosis (ALS); Lou Gehrig's disease
- Frontotemporal lobar degeneration (FTLD), including: Pick disease of brain; Frontotemporal dementia (FTD); Ubiquitin-positive frontotemporal dementia (UP-FTD); Progressive supranuclear palsy type 1 (PSNP1); Inclusion body myopathy with early-onset paget disease and frontotemporal dementia (IBMPFD); Frontotemporal dementia, chromosome 3-linked (FTD3)
- Progressive supranuclear palsy (PSP); Steele-Richardson-Olszewski syndrome
|
BAG1 and HSPA4 |
BAG cochaperone 1 |
heat shock protein family A (Hsp70) member 4 |
- Regulation of HSF1-mediated heat shock response
|
- Regulation of HSF1-mediated heat shock response
|
- (2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
|
|
|
|
ADGRB1 and ELMO1 |
adhesion G protein-coupled receptor B1 |
engulfment and cell motility 1 |
|
- Nef and signal transduction
- Regulation of actin dynamics for phagocytic cup formation
- VEGFA-VEGFR2 Pathway
- PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
- FCGR3A-mediated phagocytosis
|
|
|
|
|
ADGRB1 and PDZD2 |
adhesion G protein-coupled receptor B1 |
PDZ domain containing 2 |
|
|
|
|
|
|
ADGRB3 and ELMO1 |
adhesion G protein-coupled receptor B3 |
engulfment and cell motility 1 |
|
- Nef and signal transduction
- Regulation of actin dynamics for phagocytic cup formation
- VEGFA-VEGFR2 Pathway
- PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
- FCGR3A-mediated phagocytosis
|
|
|
|
|
BAK1 and HSPD1 |
BCL2 antagonist/killer 1 |
heat shock protein family D (Hsp60) member 1 |
- Activation and oligomerization of BAK protein
- Release of apoptotic factors from the mitochondria
|
- Mitochondrial protein import
- Mitochondrial protein import
- TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
|
|
|
|
- Hereditary spastic paraplegia (SPG)
- Hypomyelinating leukodystrophy (HLD); Pelizaeus-Merzbacher disease (PMD)
|
BAK1 and BCL2L10 |
BCL2 antagonist/killer 1 |
BCL2 like 10 |
- Activation and oligomerization of BAK protein
- Release of apoptotic factors from the mitochondria
|
|
|
|
|
|
BAK1 and NFKBIB |
BCL2 antagonist/killer 1 |
NFKB inhibitor beta |
- Activation and oligomerization of BAK protein
- Release of apoptotic factors from the mitochondria
|
- Activation of NF-kappaB in B cells
- RIP-mediated NFkB activation via ZBP1
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
- TRAF6 mediated NF-kB activation
|
|
|
|
|
BAK1 and MFN1 |
BCL2 antagonist/killer 1 |
mitofusin 1 |
- Activation and oligomerization of BAK protein
- Release of apoptotic factors from the mitochondria
|
- Pink/Parkin Mediated Mitophagy
- Factors involved in megakaryocyte development and platelet production
|
|
|
|
|
BAK1 and BAX |
BCL2 antagonist/killer 1 |
BCL2 associated X, apoptosis regulator |
- Activation and oligomerization of BAK protein
- Release of apoptotic factors from the mitochondria
|
- Release of apoptotic factors from the mitochondria
- Activation, translocation and oligomerization of BAX
- TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
- TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
- Transcriptional regulation by RUNX2
- NTRK3 as a dependence receptor
|
|
|
|
|
BAK1 and ERN1 |
BCL2 antagonist/killer 1 |
endoplasmic reticulum to nucleus signaling 1 |
- Activation and oligomerization of BAK protein
- Release of apoptotic factors from the mitochondria
|
- IRE1alpha activates chaperones
- IRE1alpha activates chaperones
|
|
- N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine
|
|
|
BAK1 and MCL1 |
BCL2 antagonist/killer 1 |
MCL1 apoptosis regulator, BCL2 family member |
- Activation and oligomerization of BAK protein
- Release of apoptotic factors from the mitochondria
|
- Interleukin-4 and Interleukin-13 signaling
|
|
|
|
|
BAK1 and BCL2 |
BCL2 antagonist/killer 1 |
BCL2 apoptosis regulator |
- Activation and oligomerization of BAK protein
- Release of apoptotic factors from the mitochondria
|
- Activation of BAD and translocation to mitochondria
- BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
- Interleukin-4 and Interleukin-13 signaling
- The NLRP1 inflammasome
- Estrogen-dependent gene expression
- Estrogen-dependent nuclear events downstream of ESR-membrane signaling
|
|
- Ibuprofen
- Paclitaxel
- Docetaxel
- Rasagiline
- S-8184
- Paclitaxel docosahexaenoic acid
- Glycine betaine
- Eribulin
- Dexibuprofen
- Venetoclax
- Obatoclax
- Navitoclax
|
|
- Choriocarcinoma
- Gastric cancer
- Chronic lymphocytic leukemia (CLL)
- Small cell lung cancer
- Kaposi's sarcoma
- Nasopharyngeal cancer
- Cervical cancer
|
BAK1 and BCL2A1 |
BCL2 antagonist/killer 1 |
BCL2 related protein A1 |
- Activation and oligomerization of BAK protein
- Release of apoptotic factors from the mitochondria
|
|
|
|
|
|
BAK1 and BCL2L1 |
BCL2 antagonist/killer 1 |
BCL2 like 1 |
- Activation and oligomerization of BAK protein
- Release of apoptotic factors from the mitochondria
|
- BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
- Interleukin-4 and Interleukin-13 signaling
- The NLRP1 inflammasome
|
|
- 4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID
- Gossypol
|
|
|
BAK1 and DBN1 |
BCL2 antagonist/killer 1 |
drebrin 1 |
- Activation and oligomerization of BAK protein
- Release of apoptotic factors from the mitochondria
|
|
|
|
|
|
BAK1 and HSD17B4 |
BCL2 antagonist/killer 1 |
hydroxysteroid 17-beta dehydrogenase 4 |
- Activation and oligomerization of BAK protein
- Release of apoptotic factors from the mitochondria
|
- Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
- alpha-linolenic acid (ALA) metabolism
- Beta-oxidation of pristanoyl-CoA
- Beta-oxidation of very long chain fatty acids
- Peroxisomal protein import
- Peroxisomal protein import
- TYSND1 cleaves peroxisomal proteins
|
|
- NADH
- 3r-Hydroxydecanoyl-Coa
|
|
- Peroxisomal beta-oxidation enzyme deficiency, including: Acyl-CoA oxidase (ACOX) deficiency; D-bifunctional protein (DBP) deficiency; Perrault syndrome; Sterol carrier protein X (SCPx) deficiency; 2-Methylacyl-CoA racemase (AMCR) deficiency; Hypercholanemia
|
BAK1 and TP53 |
BCL2 antagonist/killer 1 |
tumor protein p53 |
- Activation and oligomerization of BAK protein
- Release of apoptotic factors from the mitochondria
|
- Activation of NOXA and translocation to mitochondria
- Activation of PUMA and translocation to mitochondria
- Pre-NOTCH Transcription and Translation
- Oxidative Stress Induced Senescence
- Formation of Senescence-Associated Heterochromatin Foci (SAHF)
- Oncogene Induced Senescence
- DNA Damage/Telomere Stress Induced Senescence
- SUMOylation of transcription factors
- Autodegradation of the E3 ubiquitin ligase COP1
- Association of TriC/CCT with target proteins during biosynthesis
- TP53 Regulates Metabolic Genes
- Ub-specific processing proteases
- Ovarian tumor domain proteases
- Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
- Interleukin-4 and Interleukin-13 signaling
- TP53 Regulates Transcription of DNA Repair Genes
- TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
- TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
- TP53 Regulates Transcription of Caspase Activators and Caspases
- TP53 Regulates Transcription of Death Receptors and Ligands
- TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
- TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
- TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
- Regulation of TP53 Expression
- Regulation of TP53 Activity through Phosphorylation
- Regulation of TP53 Degradation
- Regulation of TP53 Activity through Acetylation
- Regulation of TP53 Activity through Association with Co-factors
- Regulation of TP53 Activity through Methylation
- PI5P Regulates TP53 Acetylation
- G2/M DNA damage checkpoint
- G2/M Checkpoints
- Stabilization of p53
- Transcriptional activation of cell cycle inhibitor p21
- The role of GTSE1 in G2/M progression after G2 checkpoint
- Transcriptional Regulation by VENTX
- RUNX3 regulates CDKN1A transcription
- Regulation of PTEN gene transcription
- Regulation of PTEN gene transcription
- Factors involved in megakaryocyte development and platelet production
|
|
- Acetylsalicylic acid
- Zinc
- Triethyl Phosphate
- AZD 3355
- 1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine
|
|
- Osteosarcoma
- Adrenal carcinoma
- Thyroid cancer
- Breast cancer
- Basal cell carcinoma
- Malignant melanoma
- Pancreatic cancer
- Gastric cancer
- Malignant pleural mesothelioma
- Non-small cell lung cancer
- Esophageal cancer
- Oral cancer
- Multiple myeloma
- Small cell lung cancer
- Li-Fraumeni syndrome, including: Classic Li-Fraumeni syndrome (LFS); LFS-like syndrome (LFSL)
- Glioma
- Squamous cell carcinoma
- Kaposi's sarcoma
- Cholangiocarcinoma
- Gallbladder cancer
- Cancer of the anal canal
- Hepatocellular carcinoma
- Choriocarcinoma
- Vulvar cancer
- Choroid plexus papilloma
- Burkitt lymphoma
- Adult T-cell leukemia
- Hairy-cell leukemia
- Bladder cancer
- Chronic lymphocytic leukemia (CLL)
- Penile cancer
- Endometrial Cancer
- Ovarian cancer
- Colorectal cancer
- Laryngeal cancer
- Chronic myeloid leukemia (CML)
|
BAK1 and VDAC1 |
BCL2 antagonist/killer 1 |
voltage dependent anion channel 1 |
- Activation and oligomerization of BAK protein
- Release of apoptotic factors from the mitochondria
|
- Mitochondrial protein import
- Pink/Parkin Mediated Mitophagy
- Ub-specific processing proteases
- Pyruvate metabolism
- Mitochondrial calcium ion transport
|
|
|
|
|